This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-01-27. Anything still debated is marked as such rather than presented as settled.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Also called GW501516 and endurobol. |
| Chemical formula | C21H18F3NO3S2 | Molecular weight about 453.5 g/mol. |
| Appearance | White to off-white solid | Form depends on synthesis and purity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, protected from light | Common for research chemicals. |
=== Philanthropy === In 1998, DiCaprio and his mother donated $35,000 for a "Leonardo DiCaprio Computer Center" at a library in Los Feliz. In May 2009, DiCaprio joined Kate Winslet, director James Cameron and Canadian singer Celine Dion, in a campaign to raise money to financially support the fees of the nursing home where Millvina Dean, a survivor of the RMS Titanic, was residing. DiCaprio and Winslet donated $20,000 to support Dean. In 2010, he donated $1 million to relief efforts in Haiti after the earthquake. In 2011, DiCaprio joined the Animal Legal Defense Fund's campaign to release Tony, a tiger that had spent the last decade at a truck stop in Grosse Tête, Louisiana. DiCaprio donated $61,000 to the gay rights group GLAAD in 2013. In 2016, DiCaprio donated $65,000 to the annual fundraising gala for the Children of Armenia Fund, where he was a special guest of his friend and honorary chair, Tony Shafrazi. Supporting Hurricane Harvey (2017) relief efforts, DiCaprio provided $1 million through his foundation. In 2020, DiCaprio's foundation donated $3 million to Australia bushfire relief efforts. Amidst the 2022 Russian invasion of Ukraine, the media announced DiCaprio donated $10 million to support Ukraine, although the news agency Associated Press suggested this amount was inaccurate.
=== Immediate-spin cross-matching === Immediate-spin cross-matching (ISCM) is an abbreviated form of cross-matching that is faster, but less sensitive; its primary use is to detect a mismatch between ABO blood types. It is an immediate test that involves combining the patient's serum and donor's red blood cells at room temperature, then centrifuging the sample and observing for agglutination or hemolysis. A lack of agglutination or hemolysis indicates a negative test reaction, or compatible match. ISCM is not appropriate in all circumstances; if the recipient's antibody screen is positive, or if they have had a positive antibody screen in the past, a full crossmatch is performed instead.
=== Mass photometry === Mass photometry (MP) is a rapid, in-solution, label-free method of obtaining the molecular mass of proteins, lipids, sugars and nucleic acids at the single-molecule level. The technique is based on interferometric scattered light microscopy. Contrast from scattered light by a single binding event at the interface between the protein solution and glass slide is detected and is linearly proportional to the mass of the molecule. This technique can also be used to measure sample homogeneity, to detect protein oligomerisation states, and to identify complex macromolecular assemblies (ribosomes, GroEL, AAV) and protein interactions such as protein-protein interactions. Mass photometry can accurately measure molecular mass over a wide range of molecular masses (40 kDa – 5 MDa).
== History == Migalastat was isolated as a fermentation product of the bacterium Streptomyces lydicus (strain PA-5726) in 1988 and called 1-deoxygalactonojirimycin. In 2004, it was designated orphan drug status by the U.S. FDA for the treatment of Fabry disease, as did the European Medicines Agency's CHMP in 2006. The sponsorship for the drug was transferred several times over the following years: from Amicus Therapeutics to Shire Pharmaceuticals in 2008, back to Amicus in 2010, to Glaxo in 2011, and again to Amicus in 2014. Two phase III clinical trials with a total of about 110 subjects were conducted between 2009 and 2015, one double-blind comparing the drug to placebo, and one comparing it to recombinant α-GalA without blinding. Migalastat stabilised heart and kidney function over the 30-months period of these trials. The efficacy of migalastat was demonstrated in a six-month, placebo-controlled clinical trial in 45 adults with Fabry disease. In this trial, participants treated with migalastat over six months had a greater reduction in globotriaosylceramide (GL-3) in blood vessels of the kidneys (as measured in kidney biopsy samples) as compared to participants on placebo. The safety of migalastat was studied in four clinical trials which included a total of 139 participants with Fabry disease. In September 2015, Amicus announced that it would submit a new drug application (NDA) for accelerated approval of migalastat to the FDA by the end of 2015.
In collaboration with the team at the Lawrence Livermore National Laboratory (LLNL) in Livermore, California, United States, they made an attempt on element 114 (which was predicted to be a magic number, closing a proton shell, and more stable than element 113). In 1998, the JINR–LLNL collaboration started their attempt on element 114, bombarding a target of plutonium-244 with ions of calcium-48:
Sources: en.wikipedia.org
Features of the Early Lesion: Accentuation of features of the initial lesion, such as the considerably greater loss of collagen Accumulation of lymphocytes subjacent to junctional epithelium Cytopathic alterations in resident fibroblasts Preliminary proliferation of basal cells of junctional epithelium
Nitric acid (HNO3) is by far the most important and the most stable of the nitrogen oxoacids. It is one of the three most used acids (the other two being sulfuric acid and hydrochloric acid) and was first discovered by alchemists in the 13th century. It is made by the catalytic oxidation of ammonia to nitric oxide, which is oxidised to nitrogen dioxide, and then dissolved in water to give concentrated nitric acid. In the United States of America, over seven million tonnes of nitric acid are produced every year, most of which is used for nitrate production for fertilisers and explosives, among other uses. Anhydrous nitric acid may be made by distilling concentrated nitric acid with phosphorus pentoxide at low pressure in glass apparatus in the dark. It can only be made in the solid state, because upon melting it spontaneously decomposes to nitrogen dioxide, and liquid nitric acid undergoes self-ionisation to a larger extent than any other covalent liquid as follows:
Aromatic L-amino acid decarboxylase (AADC or AAAD), also known as DOPA decarboxylase (DDC), tryptophan decarboxylase, and 5-hydroxytryptophan decarboxylase, is a lyase enzyme (EC 4.1.1.28), located in region 7p12.2-p12.1.
A Palestinian exodus from Kuwait took place during and after the Gulf War. During the Gulf War, more than 200,000 Palestinians fled Kuwait during the Iraqi occupation of Kuwait due to harassment and intimidation by Iraqi security forces, in addition to getting fired from work by Iraqi authority figures in Kuwait. After the Gulf War, the Kuwaiti authorities forcibly pressured nearly 200,000 Palestinians to leave Kuwait in 1991. Kuwait's policy, which led to this exodus, was a response to alignment of Palestinian leader Yasser Arafat and the PLO with Saddam Hussein. The Palestinians who fled Kuwait were Jordanian citizens. In 2013, 280,000 Jordanian citizens of Palestinian origin lived in Kuwait. In 2012, 80,000 Palestinians (without Jordanian citizenship) lived in Kuwait. Saudi Arabia expelled Yemeni workers after Yemen supported Saddam during the Gulf War.
Theo Wallimann (born 13 October 1946 in Alpnach, Obwalden, Switzerland) is a Swiss biologist who was research group leader and Adjunct-Professor at the Institute of Cell Biology ETH Zurich and later at the Institute of Molecular Health Science https://mhs.biol.ethz.ch/about-us/emeriti-formermembers/wallimann.html at the ETH Zurich at the Biology Department https://biol.ethz.ch/en/, of the ETH Zurich, Switzerland.
Sources: en.wikipedia.org
A study of iron-deficiency among early Mongolian nomads showed that although overall rates of cribra orbitalia declined from 28.7 percent (27.8 percent of the total female population, 28.4 percent of the total male population, 75 percent of the total juvenile population) during the Bronze and Iron Ages, to 15.5 percent during the Hunnu (2209–1907 BP) period, the rate of females with cribra orbitalia remained roughly the same, while incidence among males and children declined (29.4 percent of the total female population, 5.3 percent of the total male population, and 25 percent of the juvenile population had cribra orbitalia). This study hypothesized that adults may have lower rates of cribra orbitalia than juveniles because lesions either heal with age or lead to death. Higher rates of cribia orbitalia among females may indicate lesser health status, or greater survival of young females with cribia orbitalia into adulthood.
ENSO conditions have occurred at two- to seven-year intervals for at least the past 300 years, but most of them have been weak. El Niño may have led to the demise of the Moche c. 700 AD and other pre-Columbian Peruvian cultures. Around 1525, when Francisco Pizarro made landfall in Peru, he noted rainfall in the deserts, the first written record of the impacts of El Niño. A recent study suggests a strong El Niño effect between 1789 and 1793 caused poor crop yields in Europe, which in turn helped touch off the French Revolution. The extreme weather produced by El Niño in 1876–77 gave rise to the most deadly famines of the 19th century. The 1876 famine alone in northern China killed up to 13 million people. The phenomenon had long been of interest because of its effects on the guano industry and other enterprises that depend on biological productivity of the sea. It is recorded that as early as 1822, cartographer Joseph Lartigue, of the French frigate La Clorinde under Baron Mackau, noted the "counter-current" and its usefulness for traveling southward along the Peruvian coast. The strongest El Niño on record as of early 2026 occurred in 1877 to 1878, and led to a global famine that killed more than 50 million people—about 3-4 percent of the estimated global population. In 1888, Charles Todd suggested droughts in India and Australia tended to occur at the same time; Norman Lockyer noted the same in 1904. An El Niño connection with flooding was reported in 1894 by Victor Eguiguren (1852–1919) and in 1895 by Federico Alfonso Pezet (1859–1929).
A radionuclide (radioactive nuclide, radioisotope, radioactive isotope, or unstable isotope) is a nuclide that is unstable and known to undergo radioactive decay into a different nuclide, which may be another radionuclide (see decay chain) or be stable. Radioactive decay is a random process at the level of single atoms: it is impossible to predict when one particular atom will decay. For a collection of atoms of a single nuclide, their average decay rate can be measured, and its half-life (t1/2) calculated. Half-lives vary by 55 orders of magnitude and have no known limits. All chemical elements have radionuclides - even the lightest, hydrogen, has a well-known radionuclide, tritium (though helium, lithium, and boron have none with half-life over a second). Elements heavier than lead (Z > 82), and the elements technetium and promethium, have only radionuclides and do not exist in stable forms, though bismuth can be treated as stable with the half-life of its natural isotope being over a trillion times longer than the current age of the universe. Radiation emitted by radionuclides is almost always ionizing radiation and exposure above a certain level can cause damage to living organisms.
Taylor was not keen on Thomas taking another trip to the United States, and thought that if he had a permanent address in London he would be able to gain steady work there. She bought a property, 54 Delancey Street, in Camden Town, and in late 1951 Thomas and Caitlin lived in the basement flat. Thomas would describe the flat as his "London house of horror" and did not return there after his 1952 tour of America.
Sources: en.wikipedia.org
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.
It activates PPARδ, a nuclear receptor that influences gene expression related to lipid and energy metabolism. Animal studies show changes in endurance and lipid levels. Human effects and risks are not well established.
No, cardarine is not a steroid. It belongs to a different chemical class, the PPARδ agonists. It is also not a selective androgen receptor modulator.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.